Octant Bio is a Biotech company based in Emeryville, California. It has raised $115M in total funding. Latest round: Series B.
Octant Bio funding overview
Octant Bio is a Biotech company based in Emeryville, California. Octant Bio has raised $115M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in April 2022. The round record for Octant Bio runs through 2022; nothing later has been disclosed. Investors on record include Catalio Capital Management, Andreessen Horowitz Bio Fund, Allen & Co., 50 Years VC, Bristol Myers Squibb. 5 distinct backers are named across the disclosed rounds.
Octant Bio at a glance
Total raised
$115M
Latest round
Series B
Latest round date
April 2022
Industry
Biotech
Headquarters
Emeryville, California
Notable investors
Catalio Capital Management, Andreessen Horowitz Bio Fund, Allen & Co., 50 Years VC, Bristol Myers Squibb
Frequently asked about Octant Bio funding
How much has Octant Bio raised?
Octant Bio has raised $115M in total disclosed funding across the rounds on record.
Who has invested in Octant Bio?
Catalio Capital Management, Andreessen Horowitz Bio Fund, Allen & Co., 50 Years VC, Bristol Myers Squibb are named among the investors backing Octant Bio.
What was the latest Octant Bio funding round?
The most recent disclosed round is a Series B, announced in April 2022.
Where is Octant Bio based?
Octant Bio is based in Emeryville, California.
What sector does Octant Bio operate in?
Octant Bio is tracked under Biotech from Emeryville, California, with $115M in disclosed funding.
When did Octant Bio last raise?
The last disclosed Octant Bio round closed in April 2022 at Series B.
Totals shown for Octant Bio aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Emeryville and the investors behind them below.
